The return of thalidomide: new uses and renewed concerns--reply.
London School of Hygiene and Tropical Medicine, UK.
Diana
D
Lockwood
Anthony
A
Bryceson
D002986:Clinical Trials as Topic; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*
D007917:Leprostatic Agents; D013792:Thalidomide